Johnson & Johnson - Index

Johnson & Johnson - report - Index

2007 YEAR IN REVIEW:
Medical Devices & Diagnostics
• Meaningful Technology Solutions Address Challenging Clinical Needs
• Key Strategic Launches Expand Device and Diagnostic Portfolios
Creating a World Without Limits for
People With Diabetes
The global growth achieved by the diabetes franchise in 2007 reflected the success of
innovations designed to drive better testing compliance and outcomes for patients with
diabetes. The continued success of the ONETOUCH ® ULTRAMINI ™ Blood Glucose Meter was
complemented by the strong sales of Animas Corporation, acquired by Johnson & Johnson in
February 2006. Animas achieved strong sales growth due to the launch of the ANIMAS ® 2020
insulin pump, the smallest full-featured pump
available. Designed to make diabetes management
easier, the ANIMAS ® 2020 pump enables users to
adjust their insulin based on food intake and
activity level. In 2007, the corporation established
the Johnson & Johnson Diabetes Institute, LLC to
transform care by providing comprehensive training to
physicians, nurses and diabetes educators worldwide.
28
DePuy, Inc. Grows Through
Orthopaedic Innovations
DePuy, Inc. launched 24 new products in
2007, and its DePuy Orthopaedics, Inc.,
DePuy Spine, Inc., Codman & Shurtleff,
Inc. and DePuy Mitek, Inc. affiliates entered
into significant product development
relationships.
DePuy Orthopaedics launched the
ULTAMET ® XL and ALTRX ™ hip bearings
featuring its PINNACLE ® Acetabular Cup
System, an advanced technology for
recreating the hip’s natural ball-and-socket
joint to help increase joint stability and range
of motion in patients who require total hip
replacement. For patients with debilitating
shoulder problems, the DELTA XTEND ™
Reverse Shoulder System offers new
technology that reverses the anatomy of the
shoulder to help restore shoulder function.
The PEAK FX TM Hip Plate System provides a
new option to stabilize hip fractures while
sparing surrounding tissue, which may
support faster recovery.
DePuy Spine entered into a strategic
collaboration with Axial Biotech, Inc. to
develop a gene-based test to predict the
progression of scoliosis, an abnormal
curvature of the spine that primarily affects
children. To bring treatments for the aging
spine to market, DePuy Spine acquired
assets related to the treatment of vertebral
compression fractures from Disc-O-Tech
Medical Technologies.
Codman reached an agreement
with Hemedex, Inc. to distribute the
HEMEDEX Q FLOW 500 ™ Perfusion Probe,
the only minimally invasive device that can
measure cerebral blood flow and tissue
perfusion in absolute units in real time.
This technology will allow physicians to
better identify and manage patients at
risk from complications of stroke or
other brain injury caused by decreased
blood flow.
DePuy Mitek launched the VERSALOK ™
knotless anchor system, which provides
surgeons with versatility in arthroscopic
rotator-cuff repair, allowing them to
address various tear pathologies with one
implant and a variety of suture-passing
configurations.
First Gene-Based
Test to Detect
the Spread of
Breast Cancer
In 2007, Veridex, LLC received
U.S. FDA approval for the first
intraoperative and gene-based test
to detect the spread of breast
cancer into the lymph nodes.
The GENESEARCH ™ Breast Lymph
Node Assay can detect the spread of
cancer into the lymph nodes more
accurately than existing methodologies
and has the potential to
reduce the need for breast cancer
patients to undergo second surgeries.
Based on the innovative nature of
this test, TIME magazine named
GENESEARCH ™ one of the Top 10
Medical Breakthroughs of 2007.
Transforming
Cardiovascular Care
Through Groundbreaking
Technology
As a global leader in the growing
$1 billion electrophysiology
market, Biosense Webster, Inc.
expanded its line of product
offerings designed to provide
physicians with faster and
more precise technology for
the diagnosis and treatment
of cardiac arrhythmias.
With the 2007 U.S. FDA
approvals of the EZ STEER ™
NAV Catheter, the NAVISTAR ®
THERMOCOOL ® RMT Catheter
and the CARTOSOUND ™ Image
Integration Module, Biosense
Webster continued its focus
on the integration of precise
navigation and imaging tools
that enhance the ability of
physicians to treat patients
with a range of simple to
complex conditions.
J O H N S O N & J O H N S O N 2 0 0 7 A N N U A L R E P O R T